The Valley Desk

Clinical trial reportAdvances in therapyPublished

Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Advances in therapy
Published
Subject terms
Humans; Multiple Sclerosis, Relapsing-Remitting; Immunosuppressive Agents; Treatment Outcome; Age Factors; Adult; Aged; Middle Aged; Female; Male; Dimethyl Fumarate; Safety
PubMed ID
39570545
PubMed Central ID
PMC11782338
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal